All Stories

  1. An automated platform for tailored late-stage halogenation of pharmaceuticals
  2. Electrochemical C−O and C−N Arylation using Alternating Polarity in flow for Compound Libraries
  3. Electrochemical C−O and C−N Arylation using Alternating Polarity in flow for Compound Libraries
  4. Multistep and multivectorial assembly line library synthesis in flow
  5. Structure–Activity Relationship of Oxacyclo- and Triazolo-Containing Respiratory Syncytial Virus Polymerase Inhibitors
  6. Automated One-pot Library Synthesis with Aldehydes as Radical Precursors
  7. Enabling Electrochemical C-O and C-N Arylation Libraries using Alternating Polarity in Flow
  8. Assembly line library synthesis in flow: A multistep and multivectorial approach
  9. Multistep Library Synthesis in Flow: Production of Matrix Libraries in an Assembly Line
  10. Alcohol-alcohol cross-coupling enabled by S H 2 radical sorting
  11. Better Together: Catalyzing Innovation in Organic Synthesis via Academic-Industrial Consortia
  12. Fully Automated Flow Protocol for C(sp3)–C(sp3) Bond Formation from Tertiary Amides and Alkyl Halides
  13. Development of an Automated Platform for C(sp3)−C(sp3) Bond Formation via XAT Chemistry
  14. A biomimetic S H 2 cross-coupling mechanism for quaternary sp 3 -carbon formation
  15. 7 Flow chemistry in fine chemical production
  16. C(sp3)−C(sp3) Bond Formation via Electrochemical Alkoxylation and Subsequent Lewis Acid Promoted Reactions
  17. Flow Chemistry in Drug Discovery
  18. Flow Chemistry in Drug Discovery: Challenges and Opportunities
  19. Flow Chemistry As a Tool to Access Novel Chemical Space for Drug Discovery
  20. Synergy between supported ionic liquid-like phases and immobilized palladium N-heterocyclic carbene–phosphine complexes for the Negishi reaction under flow conditions
  21. Formation of quaternary carbons through cobalt-catalyzed C(sp3)–C(sp3) Negishi cross-coupling
  22. Organometallic Chemistry in Flow in the Pharmaceutical Industry
  23. Visible‐Light‐Promoted Iron‐Catalyzed C(sp 2 )–C(sp 3 ) Kumada Cross‐Coupling in Flow
  24. Flow Chemistry in Drug Discovery
  25. De novo Design of Organic Photocatalysts: Bithiophene Derivatives for the Visible‐light Induced C−H Functionalization of Heteroarenes
  26. Scalability of Visible-Light-Induced Nickel Negishi Reactions: A Combination of Flow Photochemistry, Use of Solid Reagents, and In-Line NMR Monitoring
  27. Photoinduced Palladium‐Catalyzed Negishi Cross‐Couplings Enabled by the Visible‐Light Absorption of Palladium–Zinc Complexes
  28. Back Cover: Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis (Angew. Chem. Int. Ed. 28/2018)
  29. Rücktitelbild: Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis (Angew. Chem. 28/2018)
  30. Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis
  31. On-demand synthesis of organozinc halides under continuous flow conditions
  32. Negishi coupling reactions with [11C]CH3I: a versatile method for efficient 11C–C bond formation
  33. Improving the throughput of batch photochemical reactions using flow: Dual photoredox and nickel catalysis in flow for C(sp2)...
  34. Visible-Light-Induced Trifluoromethylation of Highly Functionalized Arenes and Heteroarenes in Continuous Flow
  35. Grignard Reagents on a Tab: Direct Magnesium Insertion under Flow Conditions
  36. Sustainable Flow Chemistry in Drug Discovery
  37. Front cover
  38. Increasing global access to the high-volume HIV drug nevirapine through process intensification
  39. Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry
  40. Reformatsky and Blaise reactions in flow as a tool for drug discovery. One pot diversity oriented synthesis of valuable intermediates and heterocycles
  41. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
  42. Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates
  43. Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
  44. Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia
  45. Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound
  46. Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists
  47. Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia
  48. Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents
  49. First Example of Alkyl–Aryl Negishi Cross-Coupling in Flow: Mild, Efficient and Clean Introduction of Functionalized Alkyl Groups
  50. Cover Picture: Continuous Synthesis of Organozinc Halides Coupled to Negishi Reactions (Adv. Synth. Catal. 18/2014)
  51. Microwave-assisted medicinal chemistry: examples from a pharmaceutical company
  52. First Example of a Continuous-Flow Carbonylation Reaction Using Aryl Formates as CO Precursors
  53. Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1 H )-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor
  54. Continuous Synthesis of Organozinc Halides Coupled to Negishi Reactions
  55. Formation of amides when other approaches have failed
  56. ChemInform Abstract: Microwave‐Assisted Continuous Flow Organic Synthesis (MACOS)
  57. Microwave‐Assisted Continuous Flow Organic Synthesis (MACOS)
  58. Cross‐Coupling in Flow using Supported Catalysts: Mild, Clean, Efficient and Sustainable Suzuki–Miyaura Coupling in a Single Pass
  59. Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging
  60. Recent Advances in Positron Emission Tomography (PET) Radiotracers for Imaging Phosphodiesterases
  61. Preparation of amides mediated by isopropylmagnesium chloride under continuous flow conditions
  62. Application of Flow Chemistry to the Selective Reduction of Esters to Aldehydes
  63. Application of flow chemistry to the reduction of nitriles to aldehydes
  64. Synthesis, In Vivo Occupancy, and Radiolabeling of Potent Phosphodiesterase Subtype-10 Inhibitors as Candidates for Positron Emission Tomography Imaging
  65. Reproducibility and Scalability of Microwave-Assisted Reactions
  66. Influence of Polarity on the Scalability and Reproducibility of Solvent-Free Microwave-Assisted Reactions
  67. Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain
  68. ChemInform Abstract: Recent Applications of Microwave Irradiation to Medicinal Chemistry
  69. Recent Applications of Microwave Irradiation to Medicinal Chemistry
  70. Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists
  71. TRES: Multiradar-multisensor data processing assessment using opportunity targets
  72. Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep–wake architecture
  73. Applications of the Combination of Microwave and Parallel Synthesis in Medicinal Chemistry
  74. Microwave‐Assisted Medicinal Chemistry
  75. Tricyclic isoxazolines: Identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and α2-adrenoceptor antagonism
  76. Microwave Assisted Medicinal Chemistry
  77. Reproducibility and Scalability of Solvent-Free Microwave-Assisted Reactions:From Domestic Ovens to Controllable Parallel Applications
  78. Synthesis of 7-amino-3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazole derivatives displaying combined α2-adrenoceptor antagonistic and 5-HT reuptake inhibiting activities
  79. Reproducibility Across Microwave Instruments: Preparation of a Set of 24 Compounds on a Multiwell Plate under Temperature‐Controlled Conditions.
  80. Reproducibility Across Microwave Instruments:  Preparation of a Set of 24 Compounds on a Multiwell Plate under Temperature-Controlled Conditions
  81. Novel Approach towards the Synthesis of 3,3a,4,5-Tetrahydroquinolino[4,3-c]isoxazole Derivatives: Application to the Preparation of Previously Unattainable 3a,4-Dihydroazabenzopyrano[4,3-c]isoxazole Scaffolds
  82. Reproducibility across Microwave Instruments: First Example of Genuine Parallel Scale up of Compounds under Microwave Irradiation
  83. Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α2-Adrenoceptor Blocking Activity
  84. Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities. Part 2: Further exploration on the cinnamyl moiety
  85. Synthesis of novel 3-substituted-2,3-dihydro-1,4-dioxino[2,3-b]pyridines as potential new scaffolds for drug discovery: selective introduction of substituents on the pyridine ring
  86. Novel analogues of 3-substituted-2,3-dihydro-1,4-dioxino[2,3-b]pyridines: modifications in the dioxane ring
  87. Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities: a novel series of potential antidepressants
  88. Synthesis of novel aza analogues of 2-substituted-2,3-dihydro-1,4-benzodioxins as potential new scaffolds for drug discovery
  89. Synthesis and structure–activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT2A/2C receptor antagonists. Part 1
  90. Synthesis and structure–Activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT2A/2C receptor antagonists. Part 2
  91. Carbon-13 NMR spectra of imidazole 1-oxides. Comparison with the parent imidazoles
  92. Selective Synthesis of 2-, 4-, and 5-Cyano Substituted Imidazoles from Imidazole N-Oxides and Trimethylsilyl Cyanide
  93. Synthesis of Imidazole N-Oxides in Solvent-free Conditions
  94. Synthesis of 4-hydroxylamino-1-azabuta-1,3-dienes and their cyclization to 2-substituted pyrazole 1-oxides
  95. Synthesis of imidazole 1-oxides from 1,2-diimines
  96. Enhancement of hands-free telecommunications